PureTech Health PLC
NASDAQ:PRTC

Watchlist Manager
PureTech Health PLC Logo
PureTech Health PLC
NASDAQ:PRTC
Watchlist
Price: 17.55 USD -6.28% Market Closed
Market Cap: 420m USD
Have any thoughts about
PureTech Health PLC?
Write Note

P/OCF
Price to OCF

-3.4
Current
-4.5
Median
21.6
Industry
Higher than median
Lower than industry value

Price to Operating Cash Flow (P/OCF) ratio is a valuation multiple that measures the value of a company’s market capitalization relative to the operating cash flow it generates. Some analysts prefer P/OCF over P/E since earnings can be more easily manipulated than cash flows.

P/OCF
-3.4
=
Market Cap
335.2m GBX
/
Operating Cash Flow
-120.8m USD
All Countries
Close
Market Cap P/OCF
US
PureTech Health PLC
NASDAQ:PRTC
335.2m USD -3.4
FR
Pharnext SCA
OTC:PNEXF
6T USD -241 760.2
US
Abbvie Inc
NYSE:ABBV
315.4B USD 19.1
US
Amgen Inc
NASDAQ:AMGN
142B USD 19.6
US
Gilead Sciences Inc
NASDAQ:GILD
111.1B USD 11.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
106.2B USD -126.1
US
Epizyme Inc
F:EPE
94.1B EUR -465.3
AU
CSL Ltd
ASX:CSL
139.2B AUD 31.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
80.8B USD 19
US
Seagen Inc
F:SGT
39.3B EUR -75.1
NL
argenx SE
XBRU:ARGX
38.4B EUR -152.5
 
US
PureTech Health PLC
NASDAQ:PRTC
Average P/OCF: 20
Negative Multiple: -3.4
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -241 760.2
US
Abbvie Inc
NYSE:ABBV
19.1
US
Amgen Inc
NASDAQ:AMGN
19.6
US
Gilead Sciences Inc
NASDAQ:GILD
11.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -126.1
US
E
Epizyme Inc
F:EPE
Negative Multiple: -465.3
AU
CSL Ltd
ASX:CSL
31.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
19
US
S
Seagen Inc
F:SGT
Negative Multiple: -75.1
NL
argenx SE
XBRU:ARGX
Negative Multiple: -152.5

P/OCF Forward Multiples

Forward P/OCF multiple is a version of the P/OCF ratio that uses forecasted operating cash flow for the P/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/OCF
N/A
2-Years Forward
P/OCF
N/A
3-Years Forward
P/OCF
N/A